We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BOLD market cap is 54.86M. The company's latest EPS is USD -2.2168 and P/E is -1.06.
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD ($) | ||
Total Revenue | 0 | 0 |
Operating Income | -16.88M | -19.39M |
Net Income | -15.43M | -16.98M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 0 |
Operating Income | -54.8M |
Net Income | -49.43M |
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD ($) | ||
Total Assets | 117.08M | 188.2M |
Total Liabilities | 10.64M | 8.96M |
Total Equity | -141.18M | 179.25M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 129.89M |
Total Liabilities | 9.36M |
Total Equity | -127.08M |
Market Cap | 54.86M |
Price to Earnings Ratio | -1.06 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.2 |
Price to Book Ratio | 0.43 |
Dividend Yield | - |
Shares Outstanding | 22.3M |
Average Volume (1 week) | 129k |
Average Volume (1 Month) | 74.99k |
52 Week Change | -95.90% |
52 Week High | 59.97 |
52 Week Low | 2.04 |
Spread (Intraday) | 0.08 (3.15%) |
Company Name | Boundless Bio Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.boundlessbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions